Molecular Influenza Diagnostic Market - Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: M332B2BB5D9DEN
Market Monitor Global

Abstracts

Molecular assays are a new type of molecular influenza diagnostic test to detect influenza viral RNA or nucleic acids in upper respiratory tract specimens in approximately 15-30 minutes.

This report contains market size and forecasts of Molecular Influenza Diagnostic in Global, including the following market information:

Global Molecular Influenza Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Molecular Influenza Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Reverse Transcription Polymerase Chain Reaction (RT-PCR) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Molecular Influenza Diagnostic include BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience and BioMerieux, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Molecular Influenza Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Molecular Influenza Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Molecular Influenza Diagnostic Market Segment Percentages, by Type, 2021 (%)

• Reverse Transcription Polymerase Chain Reaction (RT-PCR)
• Nucleic Acid Sequence Based Amplification (NASBA) Tests
• Loop-mediated Isothermal Amplification-Based Assays (LAMP)
• Simple Amplification-based Assays (SAMBA)

Global Molecular Influenza Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Molecular Influenza Diagnostic Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• POCT
• Others

Global Molecular Influenza Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Molecular Influenza Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Molecular Influenza Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Molecular Influenza Diagnostic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• BD
• Abbott (Include Alere)
• Roche
• SIEMENS
• Analytik Jena
• Quidel
• Thermo Fisher
• Meridian Bioscience
• BioMerieux
• Sekisui Diagnostics
• Response Biomedical
• SA Scientific

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Molecular Influenza Diagnostic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Molecular Influenza Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MOLECULAR INFLUENZA DIAGNOSTIC OVERALL MARKET SIZE

2.1 Global Molecular Influenza Diagnostic Market Size: 2021 VS 2028
2.2 Global Molecular Influenza Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Molecular Influenza Diagnostic Players in Global Market
3.2 Top Global Molecular Influenza Diagnostic Companies Ranked by Revenue
3.3 Global Molecular Influenza Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Molecular Influenza Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Molecular Influenza Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Influenza Diagnostic Players in Global Market
  3.6.1 List of Global Tier 1 Molecular Influenza Diagnostic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Molecular Influenza Diagnostic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Molecular Influenza Diagnostic Market Size Markets, 2021 & 2028
  4.1.2 Reverse Transcription Polymerase Chain Reaction (RT-PCR)
  4.1.3 Nucleic Acid Sequence Based Amplification (NASBA) Tests
  4.1.4 Loop-mediated Isothermal Amplification-Based Assays (LAMP)
  4.1.5 Simple Amplification-based Assays (SAMBA)
4.2 By Type - Global Molecular Influenza Diagnostic Revenue & Forecasts
  4.2.1 By Type - Global Molecular Influenza Diagnostic Revenue, 2017-2022
  4.2.2 By Type - Global Molecular Influenza Diagnostic Revenue, 2023-2028
  4.2.3 By Type - Global Molecular Influenza Diagnostic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Molecular Influenza Diagnostic Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 POCT
  5.1.4 Others
5.2 By Application - Global Molecular Influenza Diagnostic Revenue & Forecasts
  5.2.1 By Application - Global Molecular Influenza Diagnostic Revenue, 2017-2022
  5.2.2 By Application - Global Molecular Influenza Diagnostic Revenue, 2023-2028
  5.2.3 By Application - Global Molecular Influenza Diagnostic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Molecular Influenza Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Molecular Influenza Diagnostic Revenue & Forecasts
  6.2.1 By Region - Global Molecular Influenza Diagnostic Revenue, 2017-2022
  6.2.2 By Region - Global Molecular Influenza Diagnostic Revenue, 2023-2028
  6.2.3 By Region - Global Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Molecular Influenza Diagnostic Revenue, 2017-2028
  6.3.2 US Molecular Influenza Diagnostic Market Size, 2017-2028
  6.3.3 Canada Molecular Influenza Diagnostic Market Size, 2017-2028
  6.3.4 Mexico Molecular Influenza Diagnostic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Molecular Influenza Diagnostic Revenue, 2017-2028
  6.4.2 Germany Molecular Influenza Diagnostic Market Size, 2017-2028
  6.4.3 France Molecular Influenza Diagnostic Market Size, 2017-2028
  6.4.4 U.K. Molecular Influenza Diagnostic Market Size, 2017-2028
  6.4.5 Italy Molecular Influenza Diagnostic Market Size, 2017-2028
  6.4.6 Russia Molecular Influenza Diagnostic Market Size, 2017-2028
  6.4.7 Nordic Countries Molecular Influenza Diagnostic Market Size, 2017-2028
  6.4.8 Benelux Molecular Influenza Diagnostic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Molecular Influenza Diagnostic Revenue, 2017-2028
  6.5.2 China Molecular Influenza Diagnostic Market Size, 2017-2028
  6.5.3 Japan Molecular Influenza Diagnostic Market Size, 2017-2028
  6.5.4 South Korea Molecular Influenza Diagnostic Market Size, 2017-2028
  6.5.5 Southeast Asia Molecular Influenza Diagnostic Market Size, 2017-2028
  6.5.6 India Molecular Influenza Diagnostic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Molecular Influenza Diagnostic Revenue, 2017-2028
  6.6.2 Brazil Molecular Influenza Diagnostic Market Size, 2017-2028
  6.6.3 Argentina Molecular Influenza Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Molecular Influenza Diagnostic Revenue, 2017-2028
  6.7.2 Turkey Molecular Influenza Diagnostic Market Size, 2017-2028
  6.7.3 Israel Molecular Influenza Diagnostic Market Size, 2017-2028
  6.7.4 Saudi Arabia Molecular Influenza Diagnostic Market Size, 2017-2028
  6.7.5 UAE Molecular Influenza Diagnostic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 BD
  7.1.1 BD Corporate Summary
  7.1.2 BD Business Overview
  7.1.3 BD Molecular Influenza Diagnostic Major Product Offerings
  7.1.4 BD Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
  7.1.5 BD Key News
7.2 Abbott (Include Alere)
  7.2.1 Abbott (Include Alere) Corporate Summary
  7.2.2 Abbott (Include Alere) Business Overview
  7.2.3 Abbott (Include Alere) Molecular Influenza Diagnostic Major Product Offerings
  7.2.4 Abbott (Include Alere) Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
  7.2.5 Abbott (Include Alere) Key News
7.3 Roche
  7.3.1 Roche Corporate Summary
  7.3.2 Roche Business Overview
  7.3.3 Roche Molecular Influenza Diagnostic Major Product Offerings
  7.3.4 Roche Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
  7.3.5 Roche Key News
7.4 SIEMENS
  7.4.1 SIEMENS Corporate Summary
  7.4.2 SIEMENS Business Overview
  7.4.3 SIEMENS Molecular Influenza Diagnostic Major Product Offerings
  7.4.4 SIEMENS Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
  7.4.5 SIEMENS Key News
7.5 Analytik Jena
  7.5.1 Analytik Jena Corporate Summary
  7.5.2 Analytik Jena Business Overview
  7.5.3 Analytik Jena Molecular Influenza Diagnostic Major Product Offerings
  7.5.4 Analytik Jena Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
  7.5.5 Analytik Jena Key News
7.6 Quidel
  7.6.1 Quidel Corporate Summary
  7.6.2 Quidel Business Overview
  7.6.3 Quidel Molecular Influenza Diagnostic Major Product Offerings
  7.6.4 Quidel Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
  7.6.5 Quidel Key News
7.7 Thermo Fisher
  7.7.1 Thermo Fisher Corporate Summary
  7.7.2 Thermo Fisher Business Overview
  7.7.3 Thermo Fisher Molecular Influenza Diagnostic Major Product Offerings
  7.7.4 Thermo Fisher Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
  7.7.5 Thermo Fisher Key News
7.8 Meridian Bioscience
  7.8.1 Meridian Bioscience Corporate Summary
  7.8.2 Meridian Bioscience Business Overview
  7.8.3 Meridian Bioscience Molecular Influenza Diagnostic Major Product Offerings
  7.8.4 Meridian Bioscience Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
  7.8.5 Meridian Bioscience Key News
7.9 BioMerieux
  7.9.1 BioMerieux Corporate Summary
  7.9.2 BioMerieux Business Overview
  7.9.3 BioMerieux Molecular Influenza Diagnostic Major Product Offerings
  7.9.4 BioMerieux Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
  7.9.5 BioMerieux Key News
7.10 Sekisui Diagnostics
  7.10.1 Sekisui Diagnostics Corporate Summary
  7.10.2 Sekisui Diagnostics Business Overview
  7.10.3 Sekisui Diagnostics Molecular Influenza Diagnostic Major Product Offerings
  7.10.4 Sekisui Diagnostics Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
  7.10.5 Sekisui Diagnostics Key News
7.11 Response Biomedical
  7.11.1 Response Biomedical Corporate Summary
  7.11.2 Response Biomedical Business Overview
  7.11.3 Response Biomedical Molecular Influenza Diagnostic Major Product Offerings
  7.11.4 Response Biomedical Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
  7.11.5 Response Biomedical Key News
7.12 SA Scientific
  7.12.1 SA Scientific Corporate Summary
  7.12.2 SA Scientific Business Overview
  7.12.3 SA Scientific Molecular Influenza Diagnostic Major Product Offerings
  7.12.4 SA Scientific Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
  7.12.5 SA Scientific Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Molecular Influenza Diagnostic Market Opportunities & Trends in Global Market
Table 2. Molecular Influenza Diagnostic Market Drivers in Global Market
Table 3. Molecular Influenza Diagnostic Market Restraints in Global Market
Table 4. Key Players of Molecular Influenza Diagnostic in Global Market
Table 5. Top Molecular Influenza Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Molecular Influenza Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Molecular Influenza Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Molecular Influenza Diagnostic Product Type
Table 9. List of Global Tier 1 Molecular Influenza Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Influenza Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Molecular Influenza Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Molecular Influenza Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Molecular Influenza Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Molecular Influenza Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Molecular Influenza Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Molecular Influenza Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Molecular Influenza Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Molecular Influenza Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Molecular Influenza Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Molecular Influenza Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Molecular Influenza Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Molecular Influenza Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Molecular Influenza Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Molecular Influenza Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. BD Corporate Summary
Table 31. BD Molecular Influenza Diagnostic Product Offerings
Table 32. BD Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. Abbott (Include Alere) Corporate Summary
Table 34. Abbott (Include Alere) Molecular Influenza Diagnostic Product Offerings
Table 35. Abbott (Include Alere) Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Roche Corporate Summary
Table 37. Roche Molecular Influenza Diagnostic Product Offerings
Table 38. Roche Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. SIEMENS Corporate Summary
Table 40. SIEMENS Molecular Influenza Diagnostic Product Offerings
Table 41. SIEMENS Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. Analytik Jena Corporate Summary
Table 43. Analytik Jena Molecular Influenza Diagnostic Product Offerings
Table 44. Analytik Jena Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. Quidel Corporate Summary
Table 46. Quidel Molecular Influenza Diagnostic Product Offerings
Table 47. Quidel Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Thermo Fisher Corporate Summary
Table 49. Thermo Fisher Molecular Influenza Diagnostic Product Offerings
Table 50. Thermo Fisher Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. Meridian Bioscience Corporate Summary
Table 52. Meridian Bioscience Molecular Influenza Diagnostic Product Offerings
Table 53. Meridian Bioscience Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
Table 54. BioMerieux Corporate Summary
Table 55. BioMerieux Molecular Influenza Diagnostic Product Offerings
Table 56. BioMerieux Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
Table 57. Sekisui Diagnostics Corporate Summary
Table 58. Sekisui Diagnostics Molecular Influenza Diagnostic Product Offerings
Table 59. Sekisui Diagnostics Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
Table 60. Response Biomedical Corporate Summary
Table 61. Response Biomedical Molecular Influenza Diagnostic Product Offerings
Table 62. Response Biomedical Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
Table 63. SA Scientific Corporate Summary
Table 64. SA Scientific Molecular Influenza Diagnostic Product Offerings
Table 65. SA Scientific Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Molecular Influenza Diagnostic Segment by Type in 2021
Figure 2. Molecular Influenza Diagnostic Segment by Application in 2021
Figure 3. Global Molecular Influenza Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Molecular Influenza Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Molecular Influenza Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Influenza Diagnostic Revenue in 2021
Figure 8. By Type - Global Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
Figure 12. US Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
Figure 24. China Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. BD Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott (Include Alere) Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. SIEMENS Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Analytik Jena Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Quidel Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Thermo Fisher Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Meridian Bioscience Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BioMerieux Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sekisui Diagnostics Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Response Biomedical Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. SA Scientific Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)